Navigation Links
UT Southwestern's cancer center earns National Cancer Institute designation
Date:8/4/2010

DALLAS Aug. 4, 2010 The Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center has attained National Cancer Institute (NCI) designation, an elite distinction held by only the top-tier cancer centers nationwide.

The Simmons Cancer Center is the first medical center in North Texas to attain this prestigious status, which the NCI bestows upon the nation's top cancer centers in recognition of innovative research and excellence in patient care. There are now 66 such centers in the US; other designated centers in Texas are in Houston and San Antonio.

"NCI cancer center designation is a national benchmark, and our selection provides welcome confirmation of the exceptional quality of cancer discovery and patient care at UT Southwestern," said Dr. Daniel K. Podolsky, president of the medical center. "It places the Simmons Cancer Center among the most elite centers in the country for advancing cancer research and providing cancer care."

As an NCI-designated center, the Simmons Cancer Center will receive a $7.5 million support grant over the next five years, which complements the $24.4 million in NCI grants that are currently active at UT Southwestern.

The National Cancer Institute is the world's largest organization solely dedicated to cancer research. It also is part of the National Institutes of Health, the primary federal agency responsible for conducting and supporting medical research. Through basic and clinical biomedical research and training, the NCI leads a national effort to eliminate suffering and death due to cancer. With designation by the NCI, the Simmons Cancer Center will now be able to provide cancer patients access to promising new cancer treatments only available through the network of these NCI centers.

The Simmons Cancer Center was established in 1988 through generous donations from Dallas philanthropist Harold C. Simmons and his family foundation. Mr. Simmons, his wife, Annette, and his daughters Lisa Simmons and Serena Simmons Connelly, have been enthusiastic supporters of the cancer center and its goal of attaining NCI designation. To date, the Simmonses have given and pledged more than $100 million to enhance cancer programs at UT Southwestern.

In addition to the Simmonses, more than 100 North Texas families and foundations, including many donations made through Southwestern Medical Foundation, have made major gifts to support UT Southwestern's cancer programs over the years.

Clinical care for cancer is provided by UT Southwestern faculty of the Simmons Cancer Center at UT Southwestern University Hospitals & Clinics, Parkland Memorial Hospital and Children's Medical Center Dallas, all of which are included in the NCI designation. Faculty also provide cancer services at the Dallas VA Medical Center, Methodist Richardson Cancer Center and Fort Worth's Moncrief Cancer Institute.

Dr. James K.V. Willson, director of the Simmons Cancer Center and associate dean for oncology programs at UT Southwestern, joined UT Southwestern in 2004 and began the process for securing NCI designation.

"Over the past five years UT Southwestern has made great strides in bringing together all the elements that collectively comprise an outstanding cancer center," Dr. Willson said. "NCI designation is the gold standard for elite cancer programs."

Under Dr. Willson's leadership the center has built upon the success and reputation of several nationally recognized cancer programs already in place at UT Southwestern. His efforts include the recruitment of more than 70 top cancer specialists to develop programs that complement the existing research and clinical expertise, as exemplified by Dr. Joan Schiller, chief of hematology/oncology and an internationally renowned lung cancer expert who joined the cancer center as deputy director in 2006. She and Dr. Michael White, professor of cell biology and associate director for basic science at the cancer center, have been key partners in the center's progress.

"The future of cancer care is the ability to make discoveries that can quickly impact patient care and cancer prevention," Dr. Willson said. "We have a discovery engine of amazing depth that exists in very few other places. What we've been able to do in the last five years is link that engine to our clinical teams so that we can provide not only exquisite patient care and access to the latest treatment and technology, but also the thinking that comes from having a comprehensive care team for every patient."

Dr. Podolsky said: "UT Southwestern has made an institutional commitment to innovation, to investing in new technologies, to recruiting the best medical minds, and to combining our many assets and focusing them on cancer. The NCI designation is a welcome and fitting recognition of those efforts."

Dr. Francisco Cigarroa, chancellor of the UT System, said: "This recognition is a well-deserved tribute to UT Southwestern's outstanding clinicians and researchers who have dedicated their careers to conquering cancer and also to the visionary generosity of the Harold Simmons family and many other selfless donors. Of course, the greatest benefit will be for the patients and their families as we improve their lives through prevention, research and clinical care."

With NCI designation, UT Southwestern enhances its ability to provide patients living in much of the central U.S., including Oklahoma and southern Kansas; western Arkansas, Mississippi and Louisiana; and eastern New Mexico and Colorado, access to innovative treatments available only at NCI-designated centers.


'/>"/>

Contact: Connie Piloto
connie.piloto@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert

Related medicine news :

1. Enhancing arrest of cell growth to treat cancer in mice
2. Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer
3. The National Coalition for Cancer Survivorship Joins the Commission on Cancer
4. Low forms of cyclin E reduce breast cancer drugs effectiveness
5. Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.
6. Soft drinks may increase risk of pancreatic cancer
7. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
8. Genes Play Role in Prognosis With Non-Small Cell Lung Cancers
9. Single gene mutation induces endometrial cancer
10. Certain genetic profiles associated with recurrence-free survival for non-small cell lung cancer
11. Molecular pathways linked to sex, age affect outcomes in lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... Representatives of CHA Fertility Centers ... member of their staff, Dr. Joshua J. Berger. As of May 2016, Dr. ... world-renowned facility. , Dr. Berger has received recognition for his research, his teaching and ...
(Date:6/23/2016)... ... June 23, 2016 , ... Horizon Blue Cross Blue Shield ... relief from the crushing burden of sky-high health care costs, Superior Court of ... ruling ( http://www.judiciary.state.nj.us/opinions/a2913-15a2929-15.pdf ) the court provided some analysis of the contracts ...
(Date:6/23/2016)... ... ... As part of an ongoing commitment to encourage living a healthy and ... BCBSNJ) have teamed up with New Jersey native and PGA Tour member Morgan Hoffmann ... lifestyle. , Through Healthy Steps NJ, Hoffmann will share a series of health education ...
(Date:6/23/2016)... ... ... A key metric of this success is the popularity of the Leafedin.org service ... areas that lack the kind of technology and networking framework that LeafedIn.org provide, where ... the marijuana industry, no matter how small or large, and more importantly no matter ...
(Date:6/23/2016)... ... June 23, 2016 , ... King Kullen’s Shop OnLine, the ... to yet another location: Garden City Park. This is the fourth store to be ... grocery delivery service is offered by King Kullen and allows customers to place orders ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
Breaking Medicine Technology: